Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tepoxalin targeting of ABCB1 overexpressing cancers

Tepoxalin targeting of ABCB1 overexpressing cancers

US Patent 12313632 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Cancers with loss of chromosome 16Q and/or low expression of metallothionein pro2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
Aryl hydrocarbon receptor (AHR) activator compounds as cancer therapeutics2025
DNA damage response signature guided rational design of CRISPR-based systems and2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridi2025
Agents for reversing toxic proteinopathies2024
Agents for reversing toxic proteinopathies2024